marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 11-14-2024
Evofem Biosciences Financial Ratios 2011-2024 | EVFM
Annual Financial Ratios Evofem Biosciences
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
0.1 | -0.0 | -0.3 | -1.2 | -2.6 | -0.6 | -2.1 | -1.4 | -0.3 | -1.2 | - | - | - |
P/S |
0.2 | 0.0 | 7.2 | 396.0 | - | - | - | - | - | - | - | - | - |
EPS |
10.4 | -167.4 | -23.6 | -2.1 | -2.0 | -5.7 | -1.4 | -0.9 | -3.1 | -5.4 | -29.3 | - | - |
EV (Enterprise Value) |
75.8 M | 94.6 M | 194 M | 236 M | 204 M | 98.3 M | 18.9 M | 7.78 M | -6.93 M | -50.8 M | -631 K | 3.53 M | - |
EBITDA per Share |
-3.6 | -178 | -19 | -1.54 | -1.3 | -3.53 | -4.34 | -5.21 | -18.4 | -28.4 | - | - | - |
EV/EBITDA |
-5.5 | -2.0 | -3.7 | -1.0 | -1.7 | -0.6 | 0.3 | 5.5 | - | - | - | ||
PEG |
0.0 | -0.0 | -0.0 | 0.19 | -0.04 | 0.02 | -0.09 | -0.02 | -0.01 | 0.01 | - | - | - |
P/B |
-0.1 | -0.0 | -0.6 | 131.1 | 13.3 | -3.1 | 7.7 | 1.5 | 0.6 | 0.2 | - | - | - |
P/CF |
-0.4 | -0.0 | -0.4 | -1.6 | -3.8 | -1.3 | -2.5 | -1.1 | -0.4 | -1.4 | - | - | - |
ROE % |
-79.66 | 106.82 | 196.70 | -10564.88 | -511.85 | 538.24 | -369.20 | -109.27 | -181.28 | -16.58 | - | - | - |
ROA % |
501.98 | -304.80 | -482.67 | -129.41 | -282.85 | -3134.96 | -242.63 | -101.58 | -107.59 | -14.07 | - | - | - |
ROCE % |
26.83 | 117.16 | 159.90 | -317.04 | -337.31 | 332.96 | -371.10 | -101.07 | -135.59 | -12.79 | - | - | - |
Current Ratio |
0.1 | 0.3 | 0.3 | 1.3 | 2.1 | 0.1 | 2.9 | 13.9 | 4.4 | 40.3 | - | - | - |
DSO |
68.8 | 82.1 | 166.4 | 1077.8 | - | - | - | - | - | - | - | - | - |
DIO |
198.3 | 539.6 | 667.7 | 5585.7 | - | - | - | - | - | - | - | - | - |
DPO |
896.9 | 1045.8 | 943.2 | 8299.1 | - | - | - | - | - | - | - | - | - |
Operating Cycle |
267.1 | 621.7 | 834.1 | 6663.6 | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
-629.9 | -424.1 | -109.1 | -1635.5 | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Financial Ratios Evofem Biosciences
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
-0.02 | 0.02 | -0.16 | - | 15.34 | -5.43 | -1.85 | - | 135.72 | -580.48 | -360.25 | - | -7.2 | -4.01 | -8.46 | - | -0.37 | -0.91 | -0.4 | -0.27 | -0.3 | -0.97 | -0.67 | -0.58 | -0.71 | -1.11 | -4.62 | -10.55 | -38.31 | -3.78 | -3.14 | -0.19 | -0.44 | -0.09 | -0.17 | - | -1.26 | -0.69 | -0.5 | - | -7.31 | -4.13 | -3 | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA per Share |
-0.02 | - | -0.09 | - | -0.72 | -4.53 | -2.62 | - | -27.2 | -110 | -323 | - | -4.15 | -4.87 | -8.19 | - | -0.32 | -0.39 | -0.4 | - | -0.3 | -0.32 | -0.5 | - | -0.71 | -1.11 | -1.4 | - | -4.54 | -3.19 | -2.48 | - | -0.13 | -0.18 | -0.42 | - | -1.24 | -0.67 | -0.49 | - | -3.35 | -3.57 | -4.65 | - | - | - | - | - | - | - | - | - | - | - | - |
ROE % |
-108.92 | -229.37 | -212.05 | -97.57 | -212.25 | -209.83 | -166.87 | -31.47 | 94.43 | 335.01 | -96.21 | 91.40 | -2128.27 | -4473.84 | -8010.82 | -7550.93 | -7632.26 | -5500.83 | -1817.68 | -511.85 | -366.38 | -199.22 | 127.02 | 538.24 | 480.83 | 427.49 | 330.22 | 36.37 | 37.50 | -269.02 | -328.85 | -441.82 | -522.19 | -313.74 | -295.97 | -141.31 | -147.50 | -81.19 | -44.87 | -12.14 | -12.14 | -5.95 | -2.46 | - | - | - | - | - | - | - | - | - | - | - | - |
ROA % |
442.85 | 948.19 | 871.59 | 425.61 | 637.29 | 353.52 | 178.73 | -116.15 | -225.99 | -547.51 | -342.65 | -189.95 | -217.14 | -134.49 | -151.65 | -92.49 | -137.44 | -159.01 | -236.41 | -282.85 | -611.50 | -1022.36 | -1476.72 | -3134.96 | -3254.62 | -4668.24 | -4253.37 | -2664.60 | -2270.40 | -658.32 | -547.07 | -517.07 | -461.06 | -242.92 | -213.02 | -83.87 | -89.12 | -51.34 | -30.68 | -10.30 | -10.30 | -5.05 | -2.08 | - | - | - | - | - | - | - | - | - | - | - | - |
ROCE % |
15.77 | 18.63 | 29.81 | 25.83 | 49.82 | 67.51 | 65.63 | 57.88 | 131.60 | 181.33 | -288.94 | -56.22 | -1998.02 | -4013.54 | -5215.45 | -5031.33 | -5122.77 | -3272.41 | -1687.90 | -254.99 | -176.07 | -5.71 | 170.17 | 268.29 | 271.42 | 195.63 | 98.31 | 7.03 | -8.67 | -27.50 | -50.84 | -85.37 | -156.69 | -212.32 | -229.81 | -137.85 | -140.71 | -72.24 | -36.64 | -9.71 | -9.71 | -6.85 | -3.81 | - | - | - | - | - | - | - | - | - | - | - | - |
Current Ratio |
0.3 | 0.1 | 0.1 | 0.1 | 0.2 | 0.2 | 0.3 | 0.3 | 0.3 | 0.2 | 0.2 | 0.3 | 0.5 | 1.1 | 0.9 | 1.0 | 1.0 | 1.0 | 1.0 | 2.2 | 2.2 | 2.2 | 2.2 | 0.1 | 0.1 | 0.1 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.8 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DSO |
101.6 | 97.9 | 127.2 | - | 102.8 | 233.9 | 67.0 | - | 143.7 | 88.6 | 116.6 | - | 190.3 | 148.0 | 164.4 | - | 350.2 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
132.5 | 140.4 | 200.3 | - | 149.8 | 182.1 | 360.0 | - | 307.2 | 472.0 | 645.3 | - | 979.0 | 1062.4 | 1456.4 | - | 2061.6 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
1727.2 | 1918.0 | 2222.2 | - | 805.5 | 715.3 | 1120.1 | - | 812.8 | 1044.9 | 1042.5 | - | 692.3 | 772.4 | 1545.7 | - | 3063.1 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
234.0 | 238.2 | 327.5 | - | 252.6 | 416.0 | 427.0 | - | 450.9 | 560.6 | 761.9 | - | 1169.3 | 1210.3 | 1620.8 | - | 2411.8 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
-1493.2 | -1679.7 | -1894.7 | - | -552.9 | -299.3 | -693.1 | - | -361.9 | -484.2 | -280.6 | - | 477.0 | 437.9 | 75.1 | - | -651.2 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency